
ZBL_App
A quality improvement project
About
This app provides a clear, easy-to-understand guide for patients undergoing or recovering from Mohs surgery, particularly for melanoma. It offers detailed information on skin cancers, personalized risk insights, and a care plan section for quick reference.
What's New in ZBL_App
1.0
November 21, 2025
FAQ
What is ZBL_App?
ZBL_App is a dedicated reference for patients undergoing or recovering from Mohs micrographic surgery, particularly for melanoma. It provides plain-language explanations of the procedure, details on various skin cancers, and personalized risk insights.
Is ZBL_App suitable for all skin cancers?
While ZBL_App focuses on patients undergoing Mohs surgery, it includes detailed sections for melanoma, basal cell carcinoma, and squamous cell carcinoma. It covers risk factors, warning signs, staging basics, and treatment considerations for these types.
Can ZBL_App provide medical advice?
No, ZBL_App is for educational purposes only and does not provide medical advice. It is not affiliated with any healthcare organization and cannot replace your physician's instructions. Always consult your surgeon or dermatologist for questions about your specific condition.
What kind of personalized insights does ZBL_App offer for melanoma?
For melanoma patients, ZBL_App offers personalized risk insights. This includes notes on Breslow depth and what it means if you have had multiple melanomas or a first-degree relative with melanoma.
Does ZBL_App have ads?
No, ZBL_App does not contain advertisements. It is a free application designed to provide educational resources without interruption.
What devices support ZBL_App?
ZBL_App is available on iPhone, iPad, and iPod. It is designed for Apple mobile devices.
How often is ZBL_App updated?
ZBL_App was last updated on November 21, 2025, with version 1.0. Future updates will depend on the developer's release schedule.
What is the age rating for ZBL_App?
ZBL_App has an age rating of 17+. This is likely due to the medical nature of the content discussed.


